BioSpace News Archive

Business

Biom’up Provides Business Update for the First Half of 2019 and confirms its Revenue Guidance for the year

Global, unaudited sales of HEMOBLAST™ Bellows for the first half of 2019 were €1.4 million – on track to achieve 2019 revenue guidance range of €4.0-4.5 million; projection for 15% market share in the US and main European countries remains a long-term goal

July 10, 2019
·
7 min read
Business

Start Codon strengthens senior team with key appointments

Start Codon, a new model of life science and healthcare business accelerator, announced two appointments to its senior team.

July 10, 2019
·
4 min read
Drug Development

ViiV’s HIV Drug Hits Endpoints in Late-Stage Comparison Trial

The two-drug combination of Dovato provided similar long-term viral suppression to common three-drug regimens.

July 10, 2019
·
3 min read
·
Alex Keown
Deals

Massachusetts Life Science M&A Hits $22.5 Billion So Far This Year

As the largest center for biotech startups in the U.S., the Boston/Cambridge, Massachusetts area often acts as a marker for the entire industry. Here’s a look at the Massachusetts M&A deals so far.

July 10, 2019
·
5 min read
·
Mark Terry
Business

Board Appointment: Dr Jim Esinhart, Former CEO of Chiltern International, Proposed Appointment as Non-Executive Director

Ergomed plc, a company focused on providing specialised services to the pharmaceutical industry, is pleased to announce its intention to appoint Dr Jim Esinhart as a Non-Executive Director of the Company.

July 10, 2019
·
3 min read
Biotech Bay

GBT and Advocates Launch Disease Awareness Campaign Focused on Breaking Down Stigmas Associated with Sickle Cell Disease

Company Also Launches Disease Awareness Campaign to Raise Awareness Among Physicians About the Silent Damage Caused by Sickle Cell Disease

July 10, 2019
·
6 min read
iSTAR Medical’s MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)

iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced consistent 18-month results of the first-in-human, micro-invasive glaucoma surgery STAR-I trial for the MINIject™ device in a standalone setting.

July 10, 2019
·
1 min read
Deals

Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma

Pan-RAF Program adds an Early Stage, Innovative, Precision Oncology Asset to Jazz Pharmaceuticals’ Growing R&D Portfolio

July 10, 2019
·
5 min read
Top 5 Vendors in the Addison’s Disease Therapeutics Market from 2019 to 2023 | Technavio

The advantages of modified versions over conventional dosage forms are encouraging several companies to focus on developing modified versions of the existing corticosteroid preparations, and oral corticosteroids.

July 10, 2019
·
4 min read
Business

Bayer Trendlines Ag Innovation Fund to Co-invest With Trendlines in New Company

Novel technology licensed from the Weizmann Institute of Science for biological solutions to treat bacterial diseases in crops

July 10, 2019
·
5 min read